News
Pfizer said on Tuesday its cancer drug Padcev, in combination with Merck's Keytruda, significantly improved survival rates in ...
The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.
Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...
The Food and Drug Administration is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children under 5 years old, a move that would add another barrier for parents ...
The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy ...
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
4h
mlive on MSN‘Potential exposure’ at Portage Pfizer plant sends people to hospital, MIOSHA investigating
Several workers reported symptoms of being exposed to a substance and some were taken to the hospital. The state is ...
Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the ...
Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...
1don MSN
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
Those who invested in Pfizer three years ago and hung on are not thrilled. They would have done much better with a simple S&P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results